Moloxin (Moxifloxacin)

Moxifloxacin, the active ingredient in Moloxin, is a fluoroquinolone antibiotic presented as an oral tablet for systemic use. It is indicated for the treatment of bacterial infections such as community‑acquired pneumonia, acute bacterial sinusitis, exacerbations of chronic bronchitis, and skin and soft‑tissue infections in adults. The drug is prescribed by qualified healthcare professionals based on clinical assessment.

GNH USA supplies Moloxin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide and adheres to EU quality standards.

Moloxin (moxifloxacin) is used to treat bacterial infections affecting the respiratory tract and skin.

- Community‑acquired bacterial pneumonia: eradicates the causative pathogens and improves clinical outcomes. - Acute bacterial sinusitis: reduces sinus inflammation and clears the infection. - Acute bacterial exacerbation of chronic bronchitis: controls bacterial load and relieves symptoms. - Skin and soft tissue infections: eliminates susceptible organisms and promotes healing. - Acute bacterial exacerbation of chronic bronchitis: restores lung function and prevents further deterioration.

Moloxin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools that may be watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Rash: mild skin erythema or itching. - Abdominal pain: cramp‑like discomfort.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or loss of function. - QT interval prolongation: risk of cardiac arrhythmias. - Severe allergic reactions: anaphylaxis, swelling, or breathing difficulty. - Clostridioides difficile infection: severe colitis with watery diarrhea. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Peripheral neuropathy: numbness or tingling in extremities.

When prescribing Moloxin, clinicians should consider several precautionary measures to minimize risk.

- Renal function assessment: adjust use in patients with impaired kidney function. - Tendon monitoring: advise patients to report tendon pain or swelling promptly. - QT prolongation risk: avoid in patients with known cardiac conduction abnormalities. - Elderly caution: increased susceptibility to adverse events; monitor closely. - Concomitant QT‑prolonging drugs: evaluate potential additive effects. - Store at below 25°C: keep in the original pack, protect from moisture.

Moloxin can interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: reduce absorption of moxifloxacin. - Warfarin: may increase bleeding risk. - Theophylline: elevated plasma levels can cause toxicity. - Cyclosporine: increased risk of nephrotoxicity. - NSAIDs: heightened seizure risk.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduction in efficacy. - Corticosteroids: increased risk of tendon rupture. - Diabetic agents: potential for hypoglycemia. - SSRIs: additive effect on QT interval. - Rifampicin: may lower moxifloxacin concentrations.